Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device

Yuichiro Miyazaki; Mitsuru Wada; Koichi Yoshitake; Hiroki Mochizuki; Kohei Ishibashi; Takashi Noda; Norihide Fukushima; Kengo Kusano

doi:10.1111/pace.14182

Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device

Pacing Clin Electrophysiol. 2021 Jun;44(6):1126-1129. doi: 10.1111/pace.14182. Epub 2021 Mar 11.

Authors

Yuichiro Miyazaki¹, Mitsuru Wada¹, Koichi Yoshitake², Hiroki Mochizuki², Kohei Ishibashi¹, Takashi Noda¹, Norihide Fukushima², Kengo Kusano¹

Affiliations

¹ Division of Arrhythmia and Electrophysiology, Department of Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
² Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.

PMID: 33521993
DOI: 10.1111/pace.14182

Abstract

Left ventricular assist device (LVAD) therapy is increasingly used in patients with end-stage heart failure. However, LVADs are associated with challenges, especially in the presence of a cardiac implantable electronic device. Although a leadless pacemaker (PM), the Micra™ Transcatheter Pacing System, can be used with LVADs, data regarding HeartMate 3™ LVAD are limited. In this report, we present a patient with a HeartMate 3™ LVAD who underwent successful leadless PM implantation after the removal of an infected cardiac resynchronization therapy defibrillator.

Keywords: HeartMate 3(; Leadless pacemaker; Micra Transcatheter Pacing System; electromagnetic interference; left ventricular assist device.

Publication types

Case Reports

MeSH terms

Aged
Electrocardiography
Epicardial Mapping
Female
Fluoroscopy
Heart Failure / physiopathology
Heart Failure / therapy*
Heart-Assist Devices*
Humans
Pacemaker, Artificial*
Prosthesis Design
Sarcoidosis / physiopathology
Sarcoidosis / therapy*